Esmonde T F, Will R G, Slattery J M, Knight R, Harries-Jones R, de Silva R, Matthews W B
Department of Clinical Neurosciences, Western General Hospital, Edinburgh, UK.
Lancet. 1993 Jan 23;341(8839):205-7. doi: 10.1016/0140-6736(93)90068-r.
Epidemiological surveillance of Creutzfeldt-Jakob disease (CJD) in the UK identified 21 patients who had received a blood transfusion and 29 who had donated blood, out of a total of 202 definite and probable cases. This frequency of blood transfusion or donation did not differ from that in age and sex matched controls, and the clinical features in patients with a history of blood transfusion were similar to those of classical CJD and clearly distinct from CJD in recipients of human growth hormone. This evidence does not suggest that blood transfusion is a major risk factor for CJD.
英国克雅氏病(CJD)的流行病学监测发现,在总共202例确诊和疑似病例中,有21例曾接受输血,29例曾献血。这种输血或献血的频率与年龄和性别匹配的对照组并无差异,有输血史患者的临床特征与经典型克雅氏病相似,明显有别于接受人生长激素者所患的克雅氏病。该证据并不表明输血是克雅氏病的主要危险因素。